Sign In
Buy KRTX
$329.83
+0 (+0%)
At Close: Jun 14, 2024
Karuna Therapeutics Reports Second Quarter 2021 Financial Results and Provides General Business Update
06:30am, Thursday, 05'th Aug 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Karuna Therapeutics to Present at 2021 Wedbush PacGrow Healthcare Virtual Conference
06:30am, Tuesday, 03'rd Aug 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
06:30am, Wednesday, 23'rd Jun 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising Investment
10:27am, Wednesday, 02'nd Jun 2021
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
Karuna Therapeutics to Present at Upcoming Investor Conferences
06:30am, Wednesday, 02'nd Jun 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Karuna Therapeutics to Present at Upcoming Investor Conferences
06:30am, Tuesday, 04'th May 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Karuna Therapeutics to Present at Upcoming Investor Conferences
06:30am, Thursday, 11'th Mar 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
Karuna Therapeutics Announces Pricing of Public Offering of Common Stock
09:24pm, Monday, 01'st Mar 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX) (“Karuna”), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people
Karuna Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides General Business Update
06:00am, Thursday, 25'th Feb 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psy
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commerci
BOSTON--(BUSINESS WIRE)---- $KRTX #NEJM--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living wi
Karuna Therapeutics to Participate at 10th Annual SVB Leerink Global Healthcare Conference
06:30am, Tuesday, 02'nd Feb 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics Announces Appointment of Ronald Marcus, M.D., as Senior Vice President of Medical
06:30am, Tuesday, 26'th Jan 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
06:30am, Tuesday, 05'th Jan 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics Appoints Denice Torres, J.D., to its Board of Directors
06:34am, Tuesday, 22'nd Dec 2020
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transf
